Akouos, Inc.

If you purchased Akouos, Inc. securities and would like to join the action, please click "Join This Action" below.

AKUS STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AKOUOS, INC. IS FAIR TO SHAREHOLDERS

October 18, 2022.

New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akouos, Inc. (NASDAQ: AKUS) to Eli Lilly and Company is fair to Akouos shareholders. Under the terms of the transaction, Akouos shareholders would receive $12.50 per share in cash plus one non-tradeable contingent value right per share that entitles the holder to receive up to an additional $3.00 in cash (if certain conditions are met).

The investigation concerns whether Akouos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Akouos shareholders; (2) determine whether Eli Lilly is underpaying for Akouos; and (3) disclose all material information necessary for Akouos shareholders to adequately assess and value the merger consideration. On behalf of Akouos shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Scroll to Top